CART123 + Ruxolitinib in Relapsed/Refractory AML
Clinical trial NCT06768476 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06768476
- Sponsor
- University of Pennsylvania
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-28
- Primary completion
- 2045-03-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.